A cost comparison of beta 2-agonist bronchodilators is not a cost-effectiveness comparison

Pharmacotherapy. 1996 May-Jun;16(3):484-5; discussion 486-7.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adrenergic beta-Agonists / economics*
  • Adrenergic beta-Agonists / therapeutic use
  • Asthma / drug therapy
  • Asthma / economics*
  • Cost Savings
  • Cost-Benefit Analysis
  • Humans
  • Practice Guidelines as Topic / standards

Substances

  • Adrenergic beta-Agonists